# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JP Morgan analyst Brian Ossenbeck downgrades ArcBest (NASDAQ:ARCB) from Overweight to Neutral and lowers the price target fr...
Morgan Stanley analyst Ravi Shanker maintains ArcBest (NASDAQ:ARCB) with a Overweight and lowers the price target from $180 ...
Wells Fargo analyst Christian Wetherbee initiates coverage on ArcBest (NASDAQ:ARCB) with a Overweight rating and announces P...
Stifel analyst J. Bruce Chan maintains ArcBest (NASDAQ:ARCB) with a Buy and lowers the price target from $159 to $150.
TD Cowen analyst Jason Seidl maintains ArcBest (NASDAQ:ARCB) with a Buy and lowers the price target from $177 to $148.
B of A Securities analyst Ken Hoexter maintains ArcBest (NASDAQ:ARCB) with a Underperform and lowers the price target from $...
UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:ARCB) with a Neutral and lowers the price target from $150 to $126.
JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Overweight and lowers the price target from $164 to...